Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (12)
P 1 (2)
P 2 (1)
P 4 (1)

Trial Status

Completed8
Unknown5
Recruiting5
Not Yet Recruiting2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06039306Not ApplicableRecruitingPrimary

Perioperative Immunonutrition Under Enhanced Recovery After Surgery

NCT06948305Not ApplicableNot Yet RecruitingPrimary

Evaluate the Effectiveness of the Mobile Instant Messaging Intervention

NCT03740503Recruiting

Genomic Investigation of Unusual Responders

NCT06676267Not ApplicableRecruitingPrimary

Laparoscopic Surgical Systems for Gynecological and Remote Surgical Treatment.

NCT06797479Not Yet RecruitingPrimary

Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.

NCT06780813Not ApplicableRecruiting

Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients

NCT06777225Not ApplicableEnrolling By InvitationPrimary

Breathing Exercise Application in Patients With Gynecological Cancer.

NCT02906943Recruiting

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

NCT06574256Not ApplicableCompletedPrimary

Investigation of the Effects of Online Education Application on Gynecological Cancer Patients Receiving Chemotherapy

NCT05028504Phase 2UnknownPrimary

A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer

NCT03935698Not ApplicableCompletedPrimary

Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study

NCT04341480UnknownPrimary

The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19

NCT05003973Not ApplicableUnknownPrimary

The Effectiveness of Anti-resistance Exercise on Lower Limb Lymphoedema Among Gynecological Cancer

NCT04236362Phase 1UnknownPrimary

A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer

NCT04694508Not ApplicableCompleted

Intraoperative Music Therapy in Gynecological Oncology

NCT03553784Not ApplicableCompletedPrimary

Low-Intensity CBT for Gynaecological Cancer Survivors

NCT01831089Phase 1Completed

Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors

NCT02026687Phase 4CompletedPrimary

Recovery and Analgesia After Surgery for Gynecological Cancer

NCT03714581Not ApplicableUnknown

Laser Therapy Following Radiotherapy for Gynecological Cancer

NCT01703585Completed

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

Scroll to load more

Research Network

Activity Timeline